Neomycin

規格

1404-04-2CAS番号

204-292-2EC番号

(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diolIUPAC名

C23H46N6O13化学式

614.6 g/mol分子量

neomycin; Fradiomycin; Neomas; Nivemycin; Myacyne; Neolate; 1404-04-2; Caswell No. 595; Vonamycin powder V; Neomin; Neomicina; Neomycine; Neomycinum; PIMAVECORT; (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol; I16QD7X297; VONAMYCIN; Kaomycine; Neomycin Complex; (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-((1R,2R,3S,4R,6S)-4,6-diamino-2-((2S,3R,4S,5R)-4-((2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl)oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl)oxy-3-hydroxycyclohexyl)oxyoxane-3,4-diol; RefChem:55694; CHEBI:7507; DTXSID9041073; A01AB08; A07AA01; B05CA09; D06AX04; J01GB05; R02AB01; S01AA03; S02AA07; S03AA01; 215-766-3; Framycetin; NEOMYCIN B; 119-04-0; Soframycin; Actilin; Framygen; Fradiomycin B; Enterfram; Framicetina; Framycetine; Fradiomycinum; Framycetinum; Antibiotic 10676; Neomycin B Hexaacetate; Neobrettin; Actiline; CCRIS 5462; Framidal; Framycin; Francetin; Dekamycin iii; HSDB 3242; Soframycine; Framycetin (INN); Neomycin Trisulfate Hydrate Deuterated; ANTIBIOTIQUE EF 185; Neomcin; 4BOC774388; (1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside; (2S,3S,4R,5R,6R)-5-Amino-2-(aminomethyl)-6-(((2R,3S,4R,5S)-5-(((1R,2R,3S,5R,6S)-3,5-diamino-2-(((2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-6-hydroxycyclohexyl)oxy)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl)oxy)tetrahydro-2H-pyran-3,4-diol; Neomicina [DCIT]; Framycetinum [INN-Latin]; Bycomycin; FRAMYCETIN [INN]; Neomycine [INN-French]; Neomycinum [INN-Latin]; Framycetine [INN-French]; NMY; Framicetina [INN-Spanish]; Framycetin [INN:BAN:DCF]; Jernadex; Fradiomycin Trisulfate Hydrate deuterated; (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol; 11004-65-2; Fradiomycin B;Neomycin B; Neomycin [INN:BAN]; C23H46N6O13; EINECS 204-292-2; EINECS 215-766-3; EPA Pesticide Chemical Code 006303; BRN 0101621; Mycerin; UNII-I16QD7X297; Actilin;; UNII-4BOC774388; Neomycin B;; Antibiotic 956; Neomycin B Acetate; Antibiotic produced by Streptomyces decaris. Neomycin B; NEOMYCIN B [MI]; Prestwick3_000158; Neomycin B; Fradiomycin B; SCHEMBL3279; FRAMYCETIN [WHO-DD]; BSPBio_000296; GTPL709; NEOMYCIN B [USP-RS]; 4-18-00-07476 (Beilstein Handbook Reference); BPBio1_000326; CHEBI:7508; CHEMBL184618; orb1220179; orb1707294; DTXSID2023359; y)tetrahydro-2H-pyran-3,4-diol; GLXC-10574; HMS2089P15; EBC-27391; MFCD09788228; AKOS024284361; CS-6390; DB00452; NCGC00179612-01; D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy; D-Streptamine, O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1-3)-beta-D-ribofuranosyl-(1-5))-2-deoxy-; DA-63612; FN175622; HY-17624; ST075177; AB00443887; NS00072944; C01737; D05140; T15348; AB00443887-03; EN300-7480789; MYCIFRADIN; NEOMAS; PIMAVECORT; VONAMYCIN; ANTIBIOTIC PRODUCED BY STREPTOMYCES DECARIS; Q4492348; BRD-K71013094-001-02-5; BRD-K71013094-065-01-2; BRD-K71013094-326-01-8; (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2-{[(2S,3R,4S,5R)-4-{[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxycyclohexyl]oxy}oxane-3,4-diol; (2S,3S,5R,6R)-5-amino-2-(aminomethyl)-6-(((2R,3S,4R,5S)-5-(((1R,2R,3S,5R,6S)-3,5-diamino-2-(((2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-6-hydroxycyclohexyl)oxy)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl)oxy)tetrahydro-2H-pyran-3,4-diol; 6-(2-{(4S,2R,3R,5R)-4-[(5S,6S,2R,3R,4R)-3-amino-6-(aminomethyl)-4,5-dihydroxy( 2H-3,4,5,6-tetrahydropyran-2-yloxy)]-3-hydroxy-5-(hydroxymethyl)oxolan-2-yloxy }(3S,6S,1R,2R,4R)-4,6-diamino-3-hydroxycyc; 6-(2-{(4S,2R,3R,5R)-4-[(5S,6S,2R,3R,4R)-3-amino-6-(aminomethyl)-4,5-dihydroxy( 2H-3,4,5,6-tetrahydropyran-2-yloxy)]-3-hydroxy-5-(hydroxymethyl)oxolan-2-yloxy }(3S,6S,1R,2R,4R)-4,6-diamino-3-hydroxycyclohexyloxy)(3S,2R,4R,5R,6R)-5-amino- 2-(aminomethyl)-2H; D-STREPTAMINE, O-2,6-DIAMINO-2,6-DIDEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-O-(O-2,6-DIAMINO-2,6-DIDEOXY-.BETA.-L-IDOPYRANOSYL-(1->3)-.BETA.-D-RIBOFURANOSYL-(1->5))-2-DEOXY-; D-STREPTAMINE, O-2,6-DIAMINO-2,6-DIDEOXY-.BETA.-L-IDOPYRANOSYL-(1->3)-O-.BETA.-D-RIBOFURANOSYL-(1->5)-O-(2,6-DIAMINO-2,6-DIDEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4))-2-DEOXY-; lohexyloxy)(3S,2R,4R,5R,6R)-5-amino- 2-(aminomethyl)-2H-3,4,5,6-tetrahydropyran-3,4-diol; Neomycin base別名